SAN ANTONIO, TX – 18 Apr, 2016 – Dr. Ed Davis, a San Antonio Podiatrist is celebrating his 15th year utilizing office based Extracorporeal Shockwave Treatment (ESWT) to solve the toughest cases of heel pain.
Plantar fasciitis is a painful and often debilitating condition that afflicts more than 2.5 million people in the United States every year. It is a condition that can affect anyone but more common in athletes, runners, overweight individuals or those required to stand on hard surfaces for prolonged periods of time. Dr. Davis states that heel pain caused by plantar fasciitis is the most common athletic injury he sees in his busy practice. Conservative treatment can remedy the vast majority of cases but recalcitrant or tougher cases have been treated with surgery in the past until the advent of ESWT in the US in about the year 2000. Surgery is invasive and has a success rate of only 50% compared to the 80% to 90% success rate for ESWT. Additionally, the recovery time for surgery can be 6 to 8 weeks while for ESWT the patient can return to normal activity the day after treatment.
ESWT or extracorporeal shockwave therapy is an advanced technology based on treatment for treating kidney stones originating in the late 1980s. The shockwaves refer to a type of acoustic wave that induces damaged tissue to remodel or rebuild and originated in Germany in the mid-1990s. Davis, who practiced in the Seattle area, at the time, sent patients to Canada for treatment until the technology came to the US in about the year 2000.
This office based, non-invasive procedure requires no medication and often, no anesthesia and requires only three 15 minute sessions. Dr. Ed Davis uses the latest technology in ESWT, the Swiss Dolorclast, the third generation of shockwave therapy, which is approved by the FDA. Davis states that he has experience with 6 ESWT machines or technologies but chose the Swiss Dolorclast in 2007 for use in his San Antonio podiatrist office.
Plantar fasciitis is an inflammatory condition of the fascia, which is the main supporting ligament of the foot but when the condition becomes chronic or is allowed to persist, degeneration of the fascia, termed “fasciosis” occurs. Fasciosis can be harder to treat but ESWT was the first type of regenerative technology designed to “rebuild” damaged fascia. ESWT induces angiogenesis or rebuilding of blood vessels in the fascia and assists with the initiation of the process in which the body removes diseased tissue and replaces it with healthy tissue.
Dr. Davis states that many of his patients are athletes who wish to limit downtime from training, self-employed individuals who cannot afford to take time off from work or have high deductibles who need a more cost effective treatment alternative to surgery. Third party coverage of ESWT is limited yet the cost of ESWT is about one tenth of what it was when the technology was introduced to the US in about 2001.
Distributed by Press Release Jet
Contact Person: Eddie Davis DPM FACFAS
Country: United States